Hlb

This profile gathers the share dealings of Hlb across 6 companies, led by HLB이노베이션, HLB제넥스 and HLB테라퓨틱스. Over a trading history stretching from 22 April 2021 to 2 October 2026, the count stands at 73 filings.

The open-market side counts 49 purchases for €16.7M alongside 7 sales for €3.6M. No amount is published for 40 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 19 purchases and 6 sales.

In size, the median ticket on the buying side is €338k. Scaled by market value, the purchases weigh a median 0.36% of market cap (sample: 15 purchases). On 8 out of 47 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 15 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -33.6%. They describe history only and say nothing certain about the share price ahead.

On 2 October 2026 came the latest disclosure, a transaction in HLB이노베이션. The clock since the last published purchase (9 June 2026) now reads 131 days. The median gap between a trade and its publication by DART (FSS) is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.